Abstract
This completely updated edition of Kalorama's comprehensive and indispensable
report covers the breadth of traditional IVD testing. The report contains
complete market statistics and analysis for all areas of IVD, including:
- Point-of-Care
- Clinical Chemistry
- Immunoassays
- Molecular Assays
- Hematology
- Coagulation
- Microbiology and Virology
- Blood Banking
- Histology and Cytology
Market size, growth, share, and geographic distribution, as well as trends in
technology development, regulatory and reimbursement issues, clinical care,
and business environments are discussed. Projections are made through 2010.
This new 1,000-page edition greatly expands coverage of the field and tracks
the most important developments. Expanded or added in this edition are
sections on:
- the movement toward POC and decentralization in lab medicine
- miniaturization and molecularization of devices
- geo-economic and demographic influences on markets
- non-invasive sampling
- greatly expanded market data on PGx and SNP testing
- revamped segmentation for clinical chemistry to include workstations and
immunoanalyzers
- more information about more immunoassays
- the renewed interest in microbiology/virology based on resistance and
the re-emergence of serious hospital- and community-based organisms
- world blood banking developments
- expanded sections on histology/cytology developments including emerging
areas such as tissue microarrays, circulating tumor cells, and
genomics-fueled innovation.
- In addition, there are now profiles of more than established and emerging
players in IVD with profiles of more than 421 companies, from the top tier to
emerging and niche competitors to watch.
View Cart
